Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury
Acute kidney injury (AKI) is a heterogeneous syndrome characterized by a dramatic increase in serum creatinine. Mild AKI may merely be confined to kidney damage and resolve within days; however, severe AKI commonly involves extrarenal organ dysfunction and is associated with high mortality. There is...
Saved in:
Main Authors: | Yuxiang Liu (Author), Jingai Fang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
by: Daria S. Chulpanova, et al.
Published: (2018) -
Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
by: Janaina Paulini, et al.
Published: (2016) -
Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma
by: Qiao B, et al.
Published: (2015) -
Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease
by: Chongjun Xiao, et al.
Published: (2021) -
Bergenin Activates SIRT1 as a Novel Therapeutic Agent for Osteogenesis of Bone Mesenchymal Stem Cells
by: Weiduo Hou, et al.
Published: (2019)